CNP/NPR-B效应轴与NPR-C/NEP清除途径在大鼠梗阻肾脏的表达

摘要/Abstract

摘要：

　目的　研究C-型利钠肽（CNP）/B-型利钠肽受体（NPR-B）效应轴与C-型利钠肽受体（NPR-C）/中性肽链内切酶（NEP）清除途径在单侧输尿管梗阻（UUO）大鼠肾脏的表达情况。方法　原位杂交、荧光定量PCR、免疫组化和Western blot检测UUO大鼠术后24 h、72 h、1周、2周、3周、1个月、2个月和3个月时肾脏CNP、NPR-B、NPR-C、NEP及IV型胶原mRNA和蛋白的表达情况。结果　CNP主要表达于肾小管上皮细胞，在梗阻后即刻显著增加，随疾病进展增幅逐渐衰减。CNP高表达主要归因于UUO早期NPR-B表达上调。结论　NEP和NPR参与肾小管间质纤维化病程中CNP表达调控；NPR-C和NEP表达渐增是导致CNP增幅降低的可能原因。

Abstract: 　Objectives　To study the expression features of C-type natriuretic peptide (CNP)/ natriuretic peptide receptor-B (NPR-B) axis and two parallel elimination pathways, natriuretic peptide receptor-C (NPR-C) and neutral endopeptidase (NEP) in unilateral ureteral obstruction (UUO) rats. Methods CNP, NPR-B, NPR-C, NEP, Col-IV and type IV collagen (Col-IV) mRNA and proteins were determined by in situ hybridization, real-time PCR, immunohistochemistry and western blot in UUO rats at 24h, 72h, 1w, 2w, 3w, 1m, 2m and 3m. Results CNP expression tended to be higher immediately after ligation and declined along with the progression of disease, occurring predominantly in tubular epithelial cells. A high-level CNP may attribute to the elevated expression of NPR-B in the early phase of UUO. Conclusions NEP and NPR participate in the regulation of CNP expression in tubulointerstitial fibrosis. The gradual increased expression of NPR-C and NEP may cause the subsequent decline of CNP.

赵雪奇, 汪婧, 孔海波, 胡波, 胡鹏. CNP/NPR-B效应轴与NPR-C/NEP清除途径在大鼠梗阻肾脏的表达[J]. 临床儿科杂志, 2014, 32(2): 170-177.

ZHAO Xueqi,WANG Jing,KONG Haibo,HU Bo,HU Peng. Expression of CNP/NPR-B axis and NPR-C/NEP elimination pathways in rats with unilateral ureteral obstruction　[J]. , 2014, 32(2): 170-177.

参考文献

[1] Sudoh T，Minamino N，Kangawa K，et al. C-type natriuretic peptide (CNP)：a new member of natriuretic peptide family identi?ed in porcine brain [J]. Biochem Biophys Res Commun，1990,168(2)：863-870.
[2] Johnson KR，Hoagland TM，Olson KR. Endogenous vascular synthesis of B-type and C-type natriuretic peptides in the rainbow trout [J]. J Exp Biol，2011，214(Pt 16)：2709-2717.
[3] Hodgkins KS，Schnaper HW. Tubulointerstitial injury and the progression of chronic kidney disease [J]. Pediatr Nephrol，2012，27(6)：901-909.
[4] Das S，Au E，Krazit ST，et al. Targeted disruption of guany-lyl cyclase-A/natriuretic peptide receptor-A gene provokes renal fibrosis and remodeling in null mutant mice：role of proinflammatory cytokines [J]. Endocrinology，2010，151(12)：5841-5850.
[5] Hu P，Wang J，Hu B，et al. Increased urinary C-type natriuretic peptide excretion may be an early marker of renal tubulointerstitial fibrosis [J]. Peptides，2012，37(1)：98-105.
[6] Hu P，Zhao XQ，Wang J，et al. Simplified stereological evaluation of renal morphology after unilateral ureteral obstruction [J]. Int J Med Sci，2013，10(4)：385-391.
[7] Chevalier RL. Molecular and cellular pathophysiology of obstructive nephropathy [J]. Pediatr Nephrol，1999，13(7)：612-619.
[8] Picard N，Baum O，Vogetseder A，et al. Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat [J]. Histochem Cell Biol，2008，130(1)：141-155.
[9] Ogata Y，Ishidoya S，Fukuzaki A，et al. Upregulated expression of transforming growth factor-beta，type IV collagen，and plasminogen activator inhibitor-1 mRNA are decreased after release of unilateral ureteral obstruction [J]. Tohoku J Exp Med，2002，197(3)：159-168.
[10] Kimura M，Asano M，Abe K，et al. Role of atrophic changes in proximal tubular cells in the peritubular deposition of type IV collagen in a rat renal ablation model [J]. Nephrol Dial Transplant，2005，20(8)：1559-1565.
[11] Xie P，Sun L，Nayak B，et al. C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy [J]. J Am Soc Nephrol，2009，20(4)：807-819.
[12] Hu P，Qin YH，Pei J，et al. Beneficial effect of all-trans retinoic acid (ATRA) on glomerulosclerosis rats via the down-regulation of the expression of alpha-smooth muscle actin：a comparative study between ATRA and benazepril [J]. Exp Mol Pathol，2010，89(1)：51-57.
[13] Kim SW，Li Y，Kim S，et al. Local renal and vascular natriuretic peptide system in obstructive uropathic rats [J]. Urol Res，2002， 30(2)：97-101.
[14] Surendran K，Simon TC. CNP gene expression is activated by Wnt signaling and correlates with Wnt4 expression du-ring renal injury [J]. Am J Physiol Renal Physiol，2003，284(4)：F653-F662.
[15] Chauhan SD，Nilsson H，Ahluwalia A，et al. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor [J]. Proc Natl Acad Sci U S A，2003，100(3)：1426-1431.
[16] Hu P，Wang J，Zhao XQ，et al. Overexpressed C-type natriure-tic peptide serves as an early compensatory response to counteract extracellular matrix remodeling in unilateral ureteral obstruction rats [J]. Mol Biol Rep，2013，40(2)：1429-1441.
[17] Koller KJ，Lowe DG，Bennett GL，et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP) [J]. Science,1991，252(5002)：120-123.
[18] Doi K，Ikeda T，Itoh H，et al. C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization [J]. Arterioscler Thromb Vasc Biol，2001，21(6)：930-936.
[19] Potter LR，Abbey-Hosch S，Dickey DM. Natriuretic peptides，their receptors，and cyclic guanosine monophosphate-dependent signaling functions [J]. Endocr Rev，2006，27(1)：47-72.
[20] Kramer HJ，B?cker A，Bokemeyer D，et al. Atrial natriuretic peptide and endothelin：modulators of renal function [J]. Clin Investig，1994，72(9)：703-705.
[21] Woodard GE，Li X，Rosado JA. Characteristics of the renal C-type natriuretic peptide receptor in hypertrophied and deve-loping rat kidney [J]. J Mol Endocrinol，2005，35(3)：519-530.
[22] Nagase M，Ando K，Katafuchi T，et al. Role of natriuretic peptide receptor type C in Dahl salt-sensitive hypertensive rats [J]. Hypertension，1997，30(2 Pt 1)：177-183.
[23] Jalal F，Lemay G，Zollinger M，et al. Neutral endopeptidase，a major brush border protein of the kidney proximal nephron，is directly targeted to the apical domain when expressed in Madin-Darby canine kidney cells [J]. J Biol Chem，1991，266(29)：19826-19832.
[24] Hu P，Xuan Q，Hu B，et al. Anti-neutral endopeptidase，natriure-tic peptides disarrangement，and proteinuria onset in membranous nephropathy [J]. Mol Biol Rep，2013，40(4)：2963-2967.
[25] Floras JS. Vasopeptidase inhibition：a novel approach to cardiovascular therapy [J]. Can J Cardiol，2002，18(2)：177-182.
[26] Nakhoul F，Ramadan R，Khankin E，et al. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome：different effects of antiproteinuric therapies [J]. Am J Physiol Renal Physiol，2005，289(4)：F880-F890.
[27] Wenzel UO，Wolf G，Jacob I，et al. Beneficial and adverse renal and vascular effects of the vasopeptidase inhibitor omapatrilat in renovascular hypertensive rats [J]. Nephrol Dial Transplant，2003，18(10)：2005-2013.